Company
Egis Pharmaceuticals
Pharmaceutical · Hungary
Available Indicators
81 indicators for Egis Pharmaceuticals. Each opens with a chart and the full value history.
Net Profit (HUF mil)yearly 2000-2012ROE (%)yearly 2000-2012Price/Book Value (P/BV)yearly 2000-2012Price/Earnings (P/E)yearly 2000-2012ROA (%)yearly 2000-2012Total Assets (HUF mil)yearly 2000-2012Book Value Per Share (HUF)yearly 2000-2012Earnings Per Share (EPS) (HUF)yearly 2000-2012Pre-Tax Profit (HUF mil)yearly 2000-2012Earnings Per Share Growth (%)yearly 2001-2012Shareholders' Equity (HUF mil)yearly 2000-2012Book Value Per Share Growth (%)yearly 2001-2012Capital Employed (HUF mil)yearly 2000-2012Capital Expenditures (HUF mil)yearly 2003-2012Capital Expenditures (As % of Sales) (%)yearly 2003-2012Cash & Cash Equivalents (HUF mil)yearly 2000-2012Cash Conversion Cycle (days)yearly 2000-2012Cash Earnings (HUF mil)yearly 2000-2012Cash Earnings Per Share (HUF)yearly 2000-2012Change in Working Capital (HUF mil)yearly 2003-2012Cost of Financing (%)yearly 2001-2012Cost of Goods & Services (HUF mil)yearly 2000-2012Current Assets (HUF mil)yearly 2000-2012Current Liabilities (HUF mil)yearly 2000-2012Days Payable Outstanding (days)yearly 2000-2012Days Sales Of Inventory (days)yearly 2000-2012Days Sales Outstanding (days)yearly 2000-2012Depreciation (HUF mil)yearly 2000-2012EBIT (HUF mil)yearly 2000-2012EBITDA (HUF mil)yearly 2000-2012EBITDA Growth (%)yearly 2001-2012EBITDA Margin (%)yearly 2000-2012EBIT Growth (%)yearly 2001-2012EBIT Margin (%)yearly 2000-2012Effective Tax Rate (%)yearly 2000-2012Equity And Liabilities (HUF mil)yearly 2000-2012Equity (As % Of Assets)yearly 2000-2012Extraordinary Cost (HUF mil)yearly 2000-2012Financing Cost (HUF mil)yearly 2000-2012Free Cash Flow (HUF mil)yearly 2003-2012Gross Margin (%)yearly 2000-2012Gross Profit (HUF mil)yearly 2000-2012Intangible Assets (HUF mil)yearly 2000-2012Inventories (HUF mil)yearly 2000-2012Issuance Of Debt (HUF mil)yearly 2003-2012Liabilities (HUF mil)yearly 2000-2012Long-Term Debt (HUF mil)yearly 2000-2012Minorities (HUF mil)yearly 2000-2012Net Change In Cash (HUF mil)yearly 2003-2012Net Debt (HUF mil)yearly 2000-2012Net Debt/EBITDAyearly 2000-2012Net Debt/Equityyearly 2000-2012Net Debt Growth (%)yearly 2001-2012Net Margin (%)yearly 2000-2012Net Profit Growth (%)yearly 2001-2012Non-Cash Items (HUF mil)yearly 2003-2012Non-Current Assets (HUF mil)yearly 2000-2012Non-Current Liabilities (HUF mil)yearly 2000-2012Number Of Shares (mil)yearly 2000-2012Of Which Minority Interest (HUF mil)yearly 2000-2012Other Investments (HUF mil)yearly 2003-2012Pre-Tax Profit Growth (%)yearly 2001-2012Price/Cash Earnings (P/CE)yearly 2000-2012Property, Plant & Equipment (HUF mil)yearly 2000-2012Receivables (HUF mil)yearly 2000-2012ROCE (%)yearly 2001-2012ROTEyearly 2001-2012Sales (HUF mil)yearly 2000-2012Shareholders' Equity Growth (%)yearly 2001-2012Share Price (HUF)yearly 2000-2012Short-Term Debt (HUF mil)yearly 2000-2012Tax (HUF mil)yearly 2000-2012Total Asset Growth (%)yearly 2001-2012Total Cash From Financing (HUF mil)yearly 2003-2012Total Cash From Investing (HUF mil)yearly 2003-2012Total Cash From Operations (HUF mil)yearly 2003-2012Total Debt (HUF mil)yearly 2000-2012Total Debt Growth (%)yearly 2001-2012Total Revenue Growth (%)yearly 2001-2012Trade Payables (HUF mil)yearly 2000-2012Working Capital (HUF mil)yearly 2000-2012
Whole Company
$19.99 one-off
- ✓ All 81 indicators of Egis Pharmaceuticals
- ✓ Full history, all frequencies
- ✓ Excel download
- ✓ Source & methodology included
Download Excel